Related Image: New source of heart stem cells discovered |
(Date:12/2/2009)... announced today,a feasibility study evaluating the preclinical (animal ... which combines technology from Weill,Cornell Medical College and ... inherited anemias such as Cooley,s Anemia. , ... series of technologies to expand, ex vivo,populations of ...
(Date:12/2/2009)... /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") ... infant and children,s formula, milk powder and,soybean products in ... the Spring issue of US Food & Drink Executive, ... in the food and beverage industry. , ...
(Date:12/2/2009)... AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: ... on endocrine therapy and oncology, today announced that ... granted Fast Track designation for the Company,s PI3K/Akt ... of relapsed/refractory multiple myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ...
(Date:12/2/2009)... a leading scientific magazine covering the life sciences, ranked Photometrics’ ... Innovations of 2009. , ... (PRWEB) ... from Photometrics ®, a designer and manufacturer of ...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3... 20 Bionovo, Inc. (Nasdaq: BNVI ) today ... nature of the active compound and mechanism of action for ... made at the 2009 conference of the American Association of ... the following:, , ...
... Wiggins Joins from Biogen Idec -SAN DIEGO, April 20 ... the company as Chief Business Officer. Mr. Wiggins comes ... served as Executive Vice President of Business Development, and was ... will be focusing on commercial planning and business development activities ...
... Psylin Neurosciences Inc., a joint ... Inc. and PsychoGenics, Inc. announced today that it ... PSN0041, for the treatment of depression.(Logo: ... peptide from Amylin,s proprietary polypeptide hormone library, PHORMOL, ...
Other Biology Technology:Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 2Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 3Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer 2Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer 3Psylin Neurosciences Commences Development of Compound for Depression 2Psylin Neurosciences Commences Development of Compound for Depression 3...
...
... to rapidly and reliably amplify unknown genomic ... APAgene provides hassle-free, ready-to use components, at ... are provided in each kit. The Genome ... filling, localized cloning of genomic DNA, isolating ...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
Biology Products: